Clincosm LogoSign in Get a demo

Study of Post-anesthesia Management in Patients Undergoing Neurosurgery

Sponsor
Beijing Tiantan Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT04362709
Collaborator
(none)
10,000
Enrollment
1
Location
35.7
Anticipated Duration (Months)
280.3
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The postoperative complications of neurosurgery are various and complex, which brings heavy economic and social burden to families. Timely detection and early intervention can help reduce the incidence of adverse events and mortality. The main purpose of this study is to analyze the possible factors related to postoperative complications of Neurosurgery, so as to achieve the prospective prevention and treatment of postoperative complications of neurosurgery.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational [Patient Registry]
    Anticipated Enrollment :
    10000 participants
    Observational Model:
    Cohort
    Time Perspective:
    Prospective
    Official Title:
    A Prospective Cohort Study of Post-anesthesia Management in Patients Undergoing Neurosurgery
    Actual Study Start Date :
    Dec 2, 2019
    Anticipated Primary Completion Date :
    Nov 22, 2022
    Anticipated Study Completion Date :
    Nov 22, 2022

    Arms and Interventions

    Arm Intervention/Treatment
    Postoperative complications
    No postoperative complications

    Outcome Measures

    Primary Outcome Measures

    1. The incidence of postoperative complications in neurosurgery. [5±2 days]

      The incidence of postoperative complications was diagnosed by the corresponding assessment scale.Complications include nausea, vomiting, delirium, delayed recovery, intracranial hematoma,etc.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • From October 2019 to October 2022, all patients received neurosurgery in Tiantan hospital and expected to returned to PACU.
    Exclusion Criteria:

    • Preoperative severe cognitive dysfunction ；

    • Tracheal intubation remained after operation ；

    • Refused to sign informed consent.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Beijing TianTan Hospital Beijing China 100070

    Sponsors and Collaborators

    • Beijing Tiantan Hospital

    Investigators

    • Study Chair: Yuming Peng, M.D., Ph.D, Department of Anesthesiology, Beijing Tiantan Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Yuming Peng, Associate professor, Beijing Tiantan Hospital
    ClinicalTrials.gov Identifier:
    NCT04362709
    Other Study ID Numbers:
    • 2019-10
    First Posted:
    Apr 27, 2020
    Last Update Posted:
    Jan 5, 2022
    Last Verified:
    Jan 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of Jan 5, 2022